CSII - Cardiovascular Systems, Inc.
| Previous Close | 53.77 |
| Open | 53.78 |
| Bid | 52.86 x 1100 |
| Ask | 52.90 x 800 |
| Day's Range | 52.19 - 53.78 |
| 52 Week Range | 28.59 - 55.22 |
| Volume | 266,880 |
| Avg. Volume | 266,838 |
| Market Cap | 1.86B |
| Beta (5Y Monthly) | 1.61 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.09 |
| Earnings Date | Feb 04, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 54.60 |
- Zacks
Cardiovascular Systems (CSII) Stock Hits New 52-Week High
Cardiovascular Systems (CSII) is optimistic about maintaining its growth momentum on several recent developments.
- Business Wire
Cardiovascular Systems, Inc. to Webcast Fiscal 2020 Second-Quarter Earnings Conference Call Wednesday, February 5
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host a live webcast of its fiscal 2020 second-quarter conference call on Wednesday, February 5, 2020, at 3:30 p.m. CT (4:30 p.m. ET). CSI management will discuss results for its fiscal second quarter ended December 31, 2019, and its financial outlook. CSI will issue a post-market earnings release prior to the call on February 5, 2020.
- Simply Wall St.
Update: Cardiovascular Systems (NASDAQ:CSII) Stock Gained 79% In The Last Year
If you want to compound wealth in the stock market, you can do so by buying an index fund. But you can significantly...
- Zacks
Cardiovascular Systems Sees Peripheral OAS Micro Crown Success
This is a major achievement for Cardiovascular Systems (CSII) toward strengthening its portfolio for the treatment of CLI.
- Business Wire
Cardiovascular Systems, Inc. Introduces Peripheral Orbital Atherectomy System With GlideAssist® in Europe
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient in Europe has been treated with its Stealth 360® Peripheral Orbital Atherectomy System (OAS) 1.25mm Micro Crown with GlideAssist® (1.25 Micro Crown).
- Insider Monkey
Hedge Funds Are Dumping Cardiovascular Systems Inc (CSII)
How do we determine whether Cardiovascular Systems Inc (NASDAQ:CSII) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors in the world, who spend immense amounts of time and resources studying companies. They may not always be right (no one is), but data shows […]
- Thomson Reuters StreetEvents
Edited Transcript of CSII earnings conference call or presentation 29-Oct-19 8:30pm GMT
Q1 2020 Cardiovascular Systems Inc Earnings Call
- Zacks
Cardiovascular Systems (CSII) Up 6.2% Since Last Earnings Report: Can It Continue?
Cardiovascular Systems (CSII) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Business Wire
Cardiovascular Systems, Inc. Announces Stephen Stenbeck Joins Board of Directors
Cardiovascular Systems, Inc. (CSI®) (CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced the addition of independent board member Stephen Stenbeck. Stenbeck is a retired partner of Ernst & Young LLP with 36 years of serving public and private audit clients in the medical device, retail, consumer products, distribution, airline and media and entertainment industries.
- Business Wire
Cardiovascular Systems, Inc. to Present at the Stifel 2019 Healthcare Conference
Cardiovascular Systems, Inc. , a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management will present and host investor meetings at the Stifel 2019 Healthcare Conference on Tuesday, November 19, 2019.
- Zacks
Cardiovascular Systems (CSII) Loss Wider Than Estimates in Q1
We are upbeat about the year-over-year uptick in both Coronary and peripheral device revenues within Cardiovascular Systems' (CSII) domestic market.
- Benzinga
The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 29) Cabaletta Bio Inc (NASDAQ: CABA ) Edwards Lifesciences ...
- Zacks
Cardiovascular Systems (CSII) Reports Q1 Loss, Tops Revenue Estimates
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of -88.89% and 0.72%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
Cardiovascular Systems, Inc. Reports Fiscal 2020 First-Quarter Financial Results
Conference Call Scheduled for Today, October 29, 2019, at 3:30 PM CT
- Insider Monkey
Is Cardiovascular Systems Inc (CSII) A Good Stock To Buy ?
Is Cardiovascular Systems Inc (NASDAQ:CSII) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among hedge fund investors have historically outperformed the market after […]
- Simply Wall St.
How Many Cardiovascular Systems, Inc. (NASDAQ:CSII) Shares Did Insiders Buy, In The Last Year?
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...
- Business Wire
First Patient in Middle East Treated With Cardiovascular Systems, Inc. Peripheral Orbital Atherectomy System
Cardiovascular Systems, Inc. (CSI®) (CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient in the United Arab Emirates has been treated with its Stealth 360® Peripheral Orbital Atherectomy System (OAS). The first peripheral patient in the Middle East was treated by Dr. Faisal Hasan at the Cleveland Clinic Abu Dhabi, UAE.
- Business Wire
Cardiovascular Systems, Inc. to Webcast Fiscal 2020 First-Quarter Earnings Conference Call Tuesday, October 29
Live Webcast at 3:30 p.m. CT
- American City Business Journals
Cardiovascular Systems' CEO Scott Ward's pay rose 32% last year
Scott Ward, the CEO of Cardiovascular Systems Inc., was paid more than $4.5 million in fiscal year 2019, a 32 percent bump from 2018's figure of $3.5 million. New Brighton-based Cardiovascular Systems develops medical devices for treating peripheral and coronary artery disease, conditions caused by the build-up of plaque along the walls of blood vessels.
- Simply Wall St.
Does Cardiovascular Systems, Inc. (NASDAQ:CSII) Have A Particularly Volatile Share Price?
Anyone researching Cardiovascular Systems, Inc. (NASDAQ:CSII) might want to consider the historical volatility of the...
- Zacks
Why Is Cardiovascular Systems (CSII) Up 1.8% Since Last Earnings Report?
Cardiovascular Systems (CSII) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Thomson Reuters StreetEvents
Edited Transcript of CSII earnings conference call or presentation 6-Aug-19 8:30pm GMT
Q4 2019 Cardiovascular Systems Inc Earnings Call
- GuruFocus.com
Cardiovascular Systems Inc (CSII) Files 10-K for the Fiscal Year Ended on June 30, 2019
Cardiovascular Systems Inc (CSII) files its latest 10-K with SEC for the fiscal year ended on June 30, 2019. Continue reading...
